Mohindru Mani

CIK 00016647084 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001664708

Recent Transactions

34 trades

Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2025-06-26+40,565→ 168,766 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-06-11+38,000→ 38,000 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2024-06-27+29,700→ 128,201 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2024-05-15+38,000→ 38,000 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2023-06-15+27,700→ 98,501 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2023-06-14+25,000→ 25,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2022-06-15+25,000→ 25,000 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2022-03-09+26,800→ 70,801 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2021-06-16+20,000→ 20,000 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+44,001→ 44,001 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2020-12-16+40,000→ 40,000 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-12-04$17.05/sh−4,755→ 17,441 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-12-02+8,333→ 22,196 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Employee Stock Option (Right to Buy)
2019-07-15−37,431→ 299,444 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-07-15$14.06/sh+37,431→ 51,294 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-07-15$25.00/sh−37,431→ 13,863 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-05-29$21.39/sh−2,496→ 13,863 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-05-28+8,333→ 16,359 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-03-13$14.06/sh+16,041→ 24,067 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-03-13$19.12/sh−16,041→ 8,026 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Employee Stock Option (Right to Buy)
2019-03-13−16,041→ 336,875 total
Award
Tvardi Therapeutics, Inc.$TVRD
Employee Stock Option (Right to Buy)
2019-03-06+75,000→ 75,000 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2018-12-28$12.55/sh−4,500→ 8,026 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2018-12-27+12,526→ 12,526 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2018-11-15$18.50/sh−16,042→ 0 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Employee Stock Option (Right to Buy)
2018-11-15−16,042→ 352,916 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2018-11-15$14.06/sh+16,042→ 16,042 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Employee Stock Option (Right to Buy)
2018-10-17−16,042→ 368,958 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2018-10-17$14.06/sh+16,042→ 16,042 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2018-10-17$20.19/sh−16,042→ 0 total
Award
Tvardi Therapeutics, Inc.$TVRD
Employee Stock Option (Right to Buy)
2017-08-15+385,000→ 385,000 total
Award
CURIS INC$CRIS
Employee stock option (right to buy)
2017-02-14+424,000→ 424,000 total
Award
CURIS INC$CRIS
Employee stock option (right to buy)
2016-03-29+200,000→ 200,000 total
Award
CURIS INC$CRIS
Employee stock option (right to buy)
2016-01-19+100,000→ 100,000 total

Mohindru Mani

Recent Transactions

Companies

Recent Filings

Address